Abstract
Recent studies have raised great interest in the modulation of autoimmune responses by manipulation of immunoregulatory cells. Several lymphocyte subpopulations responsible for the induction and maintenance of immune tolerance have been extensively studied, and much has been learned about their properties. Lately, a series of attempts to harness the immunoregulatory activities of these cells for therapeutic purposes has proven successful in preclinical studies. The development of new strategies for the expansion of glycolipid-induced activation of NKT cells and antigenspecific regulatory T cells represent examples that have generated considerable interest and that are leading to the development of immunoregulatory cell-based approaches translating the findings from the bench to the bedside. This review highlights the advances, obstacles and limitations of these studies and critically discusses the most recent findings in this rapidly expanding field.
Keywords: autoimmune diseases, natural killer T (NKT) cells, lipopolysaccharide (LPS), Immunoregulatory Cells, nonobese diabetic (NOD), Foxp3-deficient mice
Current Medicinal Chemistry
Title: Natural and Adaptive Immune Cell-Based Therapies in Autoimmunity
Volume: 13 Issue: 13
Author(s): Antonio L. Cava and Fu-Dong Shi
Affiliation:
Keywords: autoimmune diseases, natural killer T (NKT) cells, lipopolysaccharide (LPS), Immunoregulatory Cells, nonobese diabetic (NOD), Foxp3-deficient mice
Abstract: Recent studies have raised great interest in the modulation of autoimmune responses by manipulation of immunoregulatory cells. Several lymphocyte subpopulations responsible for the induction and maintenance of immune tolerance have been extensively studied, and much has been learned about their properties. Lately, a series of attempts to harness the immunoregulatory activities of these cells for therapeutic purposes has proven successful in preclinical studies. The development of new strategies for the expansion of glycolipid-induced activation of NKT cells and antigenspecific regulatory T cells represent examples that have generated considerable interest and that are leading to the development of immunoregulatory cell-based approaches translating the findings from the bench to the bedside. This review highlights the advances, obstacles and limitations of these studies and critically discusses the most recent findings in this rapidly expanding field.
Export Options
About this article
Cite this article as:
Cava L. Antonio and Shi Fu-Dong, Natural and Adaptive Immune Cell-Based Therapies in Autoimmunity, Current Medicinal Chemistry 2006; 13 (13) . https://dx.doi.org/10.2174/092986706777442020
DOI https://dx.doi.org/10.2174/092986706777442020 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cerebral Hypoperfusion in Hereditary Coproporphyria (HCP): A Single Photon Emission Computed Tomography (SPECT) Study
Endocrine, Metabolic & Immune Disorders - Drug Targets CCR5-Targeted Hematopoietic Stem Cell Gene Approaches for HIV Disease: Current Progress and Future Prospects
Current Stem Cell Research & Therapy Synthesis and Analgesic Activity of 3,7-dimethylpurine-2,6-dion-1-yl Derivatives of Acetic and Butanoic Acid
Letters in Drug Design & Discovery Mechanisms of T Cell Tolerance and Suppression in Cancer Mediated by Tumor-Associated Antigens and Hormones
Current Cancer Drug Targets Crystallization and Preliminary X-Ray Analysis of the Splice Variant of Human Ankyrin Repeat and Suppressor of Cytokine Signaling Box Protein 9 (hASB9-2)
Protein & Peptide Letters The Role of Autophagy in Rheumatic Disease
Current Drug Targets Prostaglandin E<sub>2</sub> Receptor 4 (EP4): A Promising Therapeutic Target for the Treatment of Cancer and Inflammatory Diseases
Current Chemical Biology Hydrogen Sulphide and Pain
Inflammation & Allergy - Drug Targets (Discontinued) Current Therapeutics, Their Problems and Thiol Metabolism as Potential Drug Targets in Leishmaniasis
Current Drug Metabolism Neuronal Death and Survival Under Oxidative Stress in Alzheimer and Parkinson Diseases
CNS & Neurological Disorders - Drug Targets Effect of Boswellia serrata Extract Microcapsule Against Ulcerative Colitis in Mice
The Natural Products Journal Focus on the Multimodal Role of Biomarkers in Breast Cancer
Current Pharmaceutical Design Continuous Renal Replacement Therapy in Children Post-Hematopoietic Stem Cell Transplantation: The Present and the Future
Current Stem Cell Research & Therapy Altered Expression of microRNAs in Serum Extracellular Vesicles in Rats with Severe Burns during Shock Stage
Current Molecular Medicine Vascular Endothelial Growth Factor (VEGF) Biochemistry and Development of Inhibitory Drugs
Current Drug Therapy Particle-based Vaccines for HIV-1 Infection
Current Drug Targets - Infectious Disorders Role of Bactericidal/Permeability-Increasing Protein (BPI) in Sepsis and Liver Cirrhosis, and Its Clinical Implications
Anti-Infective Agents A Review of Recent Patents Concerning Therapy of Respiratory Diseases Using Gene Silencing by RNAi (RISC) and EGS (RNAse P)
Recent Patents on Inflammation & Allergy Drug Discovery Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models
Anti-Cancer Agents in Medicinal Chemistry Propofol and Systemic Inflammatory Response in Abdominal Aortic Surgery
Letters in Drug Design & Discovery